Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Similar articles for PubMed (Select 11950737)

1.

Drug points: Neuropsychiatric complications of nevirapine treatment.

Wise ME, Mistry K, Reid S.

BMJ. 2002 Apr 13;324(7342):879. No abstract available.

2.

Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?

Morlese JF, Qazi NA, Gazzard BG, Nelson MR.

AIDS. 2002 Sep 6;16(13):1840-1. No abstract available.

PMID:
12218402
3.

Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART).

Prime K, French P.

Sex Transm Infect. 2001 Aug;77(4):297-8. Review. No abstract available.

4.

Nevirapine warning.

[No authors listed]

AIDS Patient Care STDS. 2004 Apr;18(4):249. No abstract available.

PMID:
15154405
5.

[Hepatitis and nevirapine].

Palacios R, Santos J, González M, Márquez M.

Med Clin (Barc). 2000 Apr 22;114(15):597-8. Spanish. No abstract available.

PMID:
10846681
6.

Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine.

de Maat MM, Beijnen JH, Schellens JH, Mulder JW.

J Infect. 2005 Apr;50(3):262-4. No abstract available.

PMID:
15780424
7.

Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.

Shahar E, Krivoy N, Weltfriend S, Pollack S.

Jpn J Infect Dis. 2004 Oct;57(5):212-3.

8.

Nevirapine-induced Stevens-Johnson syndrome in a mother and son.

Liechty CA, Solberg P, Mwima G, Were W, Weidle PJ, Mermin J.

AIDS. 2005 Jun 10;19(9):993-4. No abstract available.

PMID:
15905686
9.

Nevirapine-associated toxicity in Niger.

Meyssonnier V, Costagliola D, Caumes PE.

HIV Med. 2008 Jan;9(1):62-3. doi: 10.1111/j.1468-1293.2008.00516.x. No abstract available.

PMID:
18199174
10.

[Assessment of nevirapine liver toxicity in patients with HIV and HVC coinfection].

Rodríguez Guardado A, Maradona Hidalgo JA, Asensi Alvarez V, Cartón Sánchez JA.

Med Clin (Barc). 2004 Mar 6;122(8):317. Spanish. No abstract available.

PMID:
15030745
11.

Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.

Bundow D, Rosoff L, Aboulafia DM.

AIDS Read. 2001 Nov;11(11):577-80.

PMID:
11789021
12.

Hepatotoxicity associated with nevirapine use.

Baylor MS, Johann-Liang R.

J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):538-9. Review. No abstract available.

PMID:
15021321
13.

[Hypersensitivity syndrome to nevirapine].

Sibaud V, Billon C, Barcat D, Bernard N, Geniaux M.

Therapie. 2000 Mar-Apr;55(2):320-2. French. No abstract available.

PMID:
10967706
14.

Liver transplantation for fulminant hepatitis related to nevirapine therapy.

Buyse S, Vibert E, Sebagh M, Antonini T, Ichai P, Castaing D, Samuel D, Duclos-Vallée JC.

Liver Transpl. 2006 Dec;12(12):1880-2.

15.

HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

Gatanaga H, Yazaki H, Tanuma J, Honda M, Genka I, Teruya K, Tachikawa N, Kikuchi Y, Oka S.

AIDS. 2007 Jan 11;21(2):264-5. No abstract available.

PMID:
17197830
16.

Nevirapine-induced hepatitis treated with corticosteroids?

Leitze Z, Nadeem A, Choudhary A, Saul Z, Roberts I, Manthous CA.

AIDS. 1998 Jun 18;12(9):1115-7. No abstract available.

PMID:
9662216
17.

Safety issues about nevirapine administration in HIV-infected pregnant women.

Manfredi R, Calza L.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):365-8. No abstract available.

PMID:
17592340
18.

Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.

Otero MJ, Fuertes A, Sánchez R, Luna G.

AIDS. 1999 May 28;13(8):1004-5. No abstract available.

PMID:
10371190
19.

Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina.

Bottaro EG, Huberman MJ, Iannella Mdel C, Vesperoni FA, Scapellato PG, Errea S, Antonelli L, Cassetti LI.

J Int Assoc Physicians AIDS Care (Chic). 2010 Sep-Oct;9(5):306-12. doi: 10.1177/1545109710376250.

PMID:
20923955
20.

Neuropsychiatric effects and E.E.G. changes in niridazole therapy.

Davidson JC.

Trans R Soc Trop Med Hyg. 1969;63(5):579-81. No abstract available.

PMID:
5824279
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk